Carmel Nanthakumar

Carmel Nanthakumar

Company: GSK

Job title: Clinical Development Director


What is the Next Step in Validating Target Engagement? Identifying Innovative & Non-Invasive Biomarkers of Fibrosis to Enable Diagnosis & Monitor Efficacy 10:30 am

• Ascertaining a panel of biomarkers to improve predictive performance for early diagnosis • Developing and validating non-invasive biomarkers to demonstrate therapeutic target engagement • What kind of studies can be done to look at early signs of efficacy?Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.